Comment: Should an LDL Cholesterol Target–Based Approach Be Readopted?

Abstract

Get full access to this article

View all access options for this article.

References

White

Weeda

Nguyen

. Should an LDL-cholesterol target-based approach be readopted? Ann Pharmacother. 2018;52:175-184. doi:10.1177/1060028017722009

Anderson

Grégoire

Pearson

et al . 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for Prevention of Cardiovascular Disease in the Adult. Can J Cardiol. 2016;32:1263-1282. doi:10.1016/j.cjca.2016.07.510

Charrois

Zolezzi

Koshman

et al . A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacotherapy. 2012;32:222-233. doi:10.1002/j.1875-9114.2012.01022.x

Tsuyuki

Rosenthal

Pearson

. A randomized trial of a community-based approach to dyslipidemia management: pharmacist prescribing to achieve cholesterol targets (RxACT Study). Can Pharm J. 2016;149:283-292. doi:10.1177/1715163516662291

Tsuyuki

Al Hamarneh

Jones

Hemmelgarn

. The effectiveness of pharmacist interventions on cardiovascular risk. J Am Coll Cardiol. 2016;67:2846-2854. doi:10.1016/j.jacc.2016.03.528